Pharmacoeconomics. 2002;20 Suppl 2:9-15.

Information barriers to the implementation of economic evaluations in Japan.

Nishimura S, Torrance GW, Ikegami N, Fukuhara S, Drummond M, Schubert F.

Source

Faculty of Economics, Kyoto University, Kyoto, Japan. shuzo@econ.kyoto-u.ac.jp

Abstract

With increasing cost-containment pressures within healthcare systems worldwide, economic evaluations of medical technologies, particularly pharmaceuticals, are used to aid the allocation of expenditure and resources. Facing similar pressures, Japan will probably also introduce economic evaluation of health technology. However, the structure of the healthcare system in Japan does not lend itself naturally to the collection of the epidemiological and cost data required for economic evaluations in medicine. In addition, there are no formal methodological guidelines in place for these analyses. To overcome these information barriers in Japan, progress may be aided by the adoption of approaches used in other countries for data collection and guideline development.

PMID:: 12238944; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Choosing a Doctor or Health Care Service - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review Why has the use of health economic evaluation in Japan lagged behind that in other developed countries? [Pharmacoeconomics. 2002]
Review Why has the use of health economic evaluation in Japan lagged behind that in other developed countries?
Ikegami N, Drummond M, Fukuhara S, Nishimura S, Torrance GW, Schubert F. Pharmacoeconomics. 2002; 20 Suppl 2:1-7.
Healthcare technology assessment and the challenge to pharmacoeconomics in Japan. [Pharmacoeconomics. 1997]
Healthcare technology assessment and the challenge to pharmacoeconomics in Japan.
Hisashige A. Pharmacoeconomics. 1997 Apr; 11(4):319-33.
A systematic review of economic evaluation literature in Thailand: are the data good enough to be used by policy-makers? [Pharmacoeconomics. 2007]
A systematic review of economic evaluation literature in Thailand: are the data good enough to be used by policy-makers?
Teerawattananon Y, Russell S, Mugford M. Pharmacoeconomics. 2007; 25(6):467-79.
Review [Economic evaluation in health care]. [Wien Med Wochenschr. 2009]
Review [Economic evaluation in health care].
Zechmeister I, Radlberger P. Wien Med Wochenschr. 2009; 159(5-6):160-8.
The emerging government requirement for economic evaluation of pharmaceuticals. [Pharmacoeconomics. 1994]
The emerging government requirement for economic evaluation of pharmaceuticals.
Drummond M. Pharmacoeconomics. 1994; 6 Suppl 1:42-50.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Information barriers to the implementation of economic evaluations in Japan.
Information barriers to the implementation of economic evaluations in Japan.
Pharmacoeconomics. 2002 ;20 Suppl 2:9-15.

PubMed
Utility of pedometers for assessing physical activity: convergent validity.
Utility of pedometers for assessing physical activity: convergent validity.
Sports Med. 2002 ;32(12):795-808.

PubMed
The relationship between DST results and suicidal behavior.
The relationship between DST results and suicidal behavior.
Ann Clin Psychiatry. 2002 Jun ;14(2):83-8.

PubMed
Procalcitonin in patients with acute myocardial infarction.
Procalcitonin in patients with acute myocardial infarction.
Wien Klin Wochenschr. 2002 Mar 28 ;114(5-6):205-10.

PubMed
Morphology and therapeutic strategies for neuroendocrine tumors of the genitouri...
Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract.
Cancer. 2002 Oct 1 ;95(7):1415-20.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: